Over the past day, 29,018 new cases of coronavirus infection were detected in Russia (in the two days preceding this - 29,935 and 27,250).

The total number of reported cases of COVID-19 in the country since the start of the epidemic has reached 2,398,254.

For the entire time, 2,992,706 patients have recovered (27,397 - over the past day).

From complications that developed against the background of coronavirus infection and concomitant diseases, 53 659 people died (563 - per day).

Over the past 24 hours, most new cases of coronavirus were detected in Moscow (7315), St. Petersburg (3751), Moscow (1576), Nizhny Novgorod (505), Pskov (416) and Sverdlovsk (403) regions.

The leader in the country in terms of the total number of cases is Moscow (772 104).

In the capital, 593,939 people recovered, 10,763 patients died.

According to the Rospotrebnadzor, more than 88 million tests for COVID-19 have been carried out in the country, over 641 thousand people remain under medical supervision.

Also, the chief sanitary doctor of the Russian Federation Anna Popova in an interview with the Russia 24 TV channel indicated that measures against COVID-19 have led to a decrease in the incidence of other acute respiratory diseases, as well as intestinal infections (including dysentery and salmonellosis).

“The measures that we have taken in the fight against the coronavirus have allowed us this year to achieve, in fact, a decrease in the incidence of measles, diphtheria, whooping cough, acute respiratory infections by almost three times,” she said.

Around the world since the beginning of the pandemic (March 11), over 79 million cases of COVID-19 have been identified, according to data from Johns Hopkins University.

The United States (18.6 million), India (10.1 million) and Brazil (7.4 million) have the largest number of reported cases of coronavirus.

The same three countries lead the anti-rating on the number of deaths from complications caused by COVID-19: the United States (329 thousand), Brazil (189 thousand), India (146 thousand).

Immunity and vaccination

Immunity after injection with the Sputnik V vaccine is higher than after a person has had a coronavirus infection.

This was stated by the virologist of the National Research Center for Epidemiology and Microbiology named after N.F.

Gamalei Alexander Butenko.

“People acquire immunity either as a result of a previous infection in any form - asymptomatic, mild, moderate, - or with the help of a vaccine - the mechanism is the same.

As a result, the population of people who are sensitive, susceptible and can get sick with coronavirus will simply be limited, ”he said on Sputnik radio.

In turn, the director of the state scientific center of virology and biotechnology "Vector" Rinat Maksyutov pointed out that some of those who have recovered from COVID-19 may develop lifelong immunity to infection.

“A number of those who have been ill can develop lifelong immunity, most of those who have been ill have reduced immunity, and six, maximum ten months after the illness, additional stimulation of the immune system will be required,” he said in the film Naili Asker-zade on the Russia 1 channel.

We add that the EpiVacCorona vaccine developed by the Vector Center was first delivered to the Khabarovsk Territory.

The regional Ministry of Health indicated that the drug also requires two injections, repeated after 21 days.

At the same time, the indications for the use of the vaccine are similar to those of "Sputnik V" - from 18 to 60 years old.

“The next batch of vaccine arrived in the region the day before.

1400 doses of "Sputnik V" were delivered, in addition, the Territory received the first vaccine "EpiVacCorona", developed at the Novosibirsk enterprise "Vector".

There are 700 doses in the batch, ”the message says.

Recall that on December 15, large-scale vaccination against coronavirus infection began in all regions of Russia.

  • © RIA Novosti / Vladimir Astapkovich

In addition, the developer of "Sputnik V" - the National Research Center for Epidemiology and Microbiology named after N.F. Gamaleya, is ready to present a project to study a vaccine in children.

This can happen within a month after the Ministry of Health analyzes data from studies on elderly people.

"How will they (the Ministry of Health. -

RT

) enter data on older age, after that, I hope, within two to three weeks, maybe a month, I am ready to submit to the Ministry of Health a draft study of this drug on groups of children," the TASS chapter quotes center of Alexander Gintsburg.